The coming years will see the U.S. face the demographic reality of the continued aging of the Baby Boomer demographic, whose oldest members are now aged 72 years. As this group ages and demands more healthcare, payers will likely find themselves under growing pressure to find ways to contain costs. A pushback on drug prices has already begun.